Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Alzheimer Research

• Publication date

  2009-07-31

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2174/156720509788929336PMID 19689233PMCID PMC2887763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.

  2009cited by this paper
• Biochemical markers in persons with preclinical familial Alzheimer disease

  2008cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

  2007cited by this paper
• Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• PET of brain amyloid and tau in mild cognitive impairment.

  2006cited by this paper
• Subtype of Mild Cognitive Impairment and Progression to Dementia and Death

  2006cited by this paper
• MRS shows abnormalities before symptoms in familial Alzheimer disease

  2006cited by this paper
• Mild cognitive impairment

  2006cited by this paper
• Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

  2006cited by this paper
• Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI

  2006cited by this paper
• Progressive Posterior Cortical Dysfunction: A Clinicopathologic Series

  2006cited by this paper
• Vitamin E and donepezil for the treatment of mild cognitive impairment.

  2005cited by this paper
• Neuropsychological function in nondemented carriers of presenilin-1 mutations

  2005influential reference
• Familial Alzheimer disease: Decreases in CSF Aβ42 levels precede cognitive decline

  2005cited by this paper
• What the Study of Persons At Risk for Familial Alzheimer's Disease Can Tell Us About the Earliest Stages of the Disorder: A Review

  2005cited by this paper
• Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations.

  2004cited by this paper
• Progressive posterior cortical dysfunction

  2004cited by this paper
• Spanish and English Neuropsychological Assessment Scales (SENAS): further development and psychometric characteristics.

  2004cited by this paper
• Pathological heterogeneity of clinically diagnosed corticobasal degeneration.

  2003cited by this paper
• Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

  2002cited by this paper
• Variant Alzheimer Disease With Spastic Paraparesis: Neuropathological Phenotype

  2001cited by this paper
• Studies of Interference in Serial Verbal Reactions

  2001cited by this paper
• Preclinical prediction of AD using neuropsychological tests

  2001cited by this paper
• An autopsy case of Alzheimer's disease presenting with primary progressive aphasia: A clinicopathological and immunohistochemical study

  2000cited by this paper
• Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

  2000cited by this paper
• Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation

  2000cited by this paper
• Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Neuropsychological evaluation of the spanish-speaker: A reply to artiola I fortuny (1996)

  1999cited by this paper
• Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

  1998cited by this paper
• Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type

  1997cited by this paper
• Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.

  1997cited by this paper
• The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits.

  1996cited by this paper
• Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

  1995cited by this paper
• Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease.

  1995cited by this paper
• Neuropsychological Evaluation of the Spanish Speaker

  1994cited by this paper
• Phenotype of chromosome 14–linked familial Alzheimer's disease in a large kindred

  1994cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

  1991cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• CME Practice parameter:

  year unknowncited by this paper

• Acupuncture for mild cognitive impairment in elderly people

  2020cites this paper
• Reaction time and response inhibition in autosomal dominant Alzheimer's disease.

  2020cites this paper
• The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China

  2019cites this paper
• Kai Xin San ameliorates scopolamine-induced cognitive dysfunction

  2019cites this paper
• Etude du métabolisme des pyramides du néocortex dans un modèle murin de la maladie d'Alzheimer - voies de signalisations impliquées dans la modulation de l'excitabilité des pyramides du néocortex par la noradrénaline

  2017cites this paper
• Cognitive Impairment in Later Life: Understanding Lay, Professional and Memory Service User Perspectives

  2017cites this paper
• Frequency of APOE, ACE, MTHFR an CCR5 Polymorphisms in Patients with Mild Cognitive Impairment in Costa Rican Population

  2016cites this paper
• Explorer Visual short-term memory binding deficits in familial Alzheimer ' s disease

  2016cites this paper
• Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment

  2016cites this paper
• Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze

  2016cites this paper
• Functional connectivity in autosomal dominant and late-onset Alzheimer disease.

  2014cites this paper
• Association Between Sleep Characteristics and Mild Cognitive Impairment in Elderly People

  2014cites this paper
• Wnt/β-catenin signaling in Alzheimer's disease.

  2014cites this paper
• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

  2013cites this paper
• Proteomic analysis of plasma from a Tau transgenic mouse

  2012cites this paper
• Conformation-Dependent Oligomers in Cerebrospinal Fluid of Presymptomatic Familial Alzheimer's Disease Mutation Carriers

  2012cites this paper
• Home-based computerized cognitive assessment tool for dementia screening

  2012cites this paper
• Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

  2011cites this paper
• Dual Task Abilities as a Possible Preclinical Marker of Alzheimer's Disease in Carriers of the E280A Presenilin-1 Mutation

  2011cites this paper
• Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer’s Disease

  2011cites this paper
• Potential Predictors of Hippocampal Atrophy in Alzheimer’s Disease

  2011cites this paper
• Title Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer ’ s disease Permalink

  2010cites this paper
• Visual short-term memory binding deficits in familial Alzheimer's disease.

  2010cites this paper
• Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer’s disease

  2010cites this paper